Metastatic CMM tumors displayed moderate to high cytoplasmic and membranous ERBB3 and MET expression in 12/13 (92%) and 9/21 (43%) BRAF-mutated tumor samples, respectively (Fig. 1b, Supplementary Table 1). The gene discussed is ERBB3; the disease is neoplasm.